MJT & Associates Financial Advisory Group, Inc.
Position in HALO — Halozyme Therapeutics, Inc.
CIK 2065777
MONTEVICEO, MN
Position in HALO
as of Jun 30, 2026
· filed Jul 6, 2026
Position Value
$3,209
+$754 QoQ
Shares Held
41
+7.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#41
of 50 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MJT & Associates Financial Advisory Group, Inc. holds $11,525 across 6 Biotechnology names. HALO ranks #2 (27.8% of the industry book) .
All Filings in HALO
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,209 | 41 | Shares | Sole | 2026-07-06 | |
| 2026-03-31 | $2,455 | 38 | Shares | Sole | 2026-04-02 | |
| 2025-12-31 | $2,557 | 38 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $2,786 | 38 | Shares | Sole | 2025-10-15 | |
| No filing history on record for this holder in this stock. | ||||||